Bengaluru, Karnataka, India
I lead large-scale biologics and sterile drug manufacturing, expansion, and transformation projects —building and scaling high performance operations from concept to commercial success. With two decades of experience in biopharma, I currently serve as Associate Vice President – Site Operations with full accountability across DS Manufacturing, Sterile Fill-Finish, Engineering, EHS, and site-wide performance. I operate at the intersection of strategy and execution—driving growth, optimizing cost structures, and ensuring global regulatory compliance. My experience spans commissioning greenfield facilities, scaling manufacturing from R&D to commercial scale and leading complex expansion programs aligned to long-term business objectives. I have consistently delivered measurable business outcomes—improving revenue, reducing COGS, enhancing yield, and increasing operational efficiency through lean and data-driven transformation. I hold an Executive MBA, am a Lean Six Sigma Black Belt, and certified in Project Management from IIT Delhi—enabling me to align operational strategy with business goals to deliver both technical excellence and strong financial performance. What differentiates my leadership approach is the ability to combine deep technical expertise in biologics manufacturing with strong business acumen. I focus not just on running operations, but on building scalable, future-ready manufacturing ecosystems that enable sustainable growth. Key areas of impact include: • Building and scaling biologics manufacturing platforms (greenfield to commercial launch) • Driving enterprise-level cost optimization and operational excellence initiatives • Leading global-standard regulatory readiness (USFDA, MHRA, EU GMP, WHO) • Executing tech transfer and commercialization strategies across complex product portfolios • Developing high-performance teams and leadership pipelines I am particularly passionate about transforming traditional manufacturing models into agile, efficient, and globally competitive systems—leveraging innovation, operation excellence, digitalization, and lean principles. Going forward, I am keen to contribute at a broader enterprise level—leading multi-site/global operations, large-scale expansion programs, and business transformation initiatives within global biopharma organizations.